tiprankstipranks
Heron Therapeutics (HRTX)
NASDAQ:HRTX
Holding HRTX?
Track your performance easily

Heron Therapeutics (HRTX) Financial Statements

1,509 Followers

Heron Therapeutics Financial Overview

Heron Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.184; its P/E ratio is -6.07; Heron Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 32.81M$ 36.02M$ 34.67M$ 34.23M$ 31.43M
Gross Profit$ 23.35M$ 25.51M$ 26.23M$ 24.35M$ 13.23M
EBIT$ -4.85M$ -9.23M$ -3.16M$ -6.30M$ -24.93M
EBITDA$ -3.89M$ -7.81M$ -2.97M$ -5.58M$ -24.20M
Net Income Common Stockholders$ -4.85M$ -9.23M$ -3.16M$ -10.72M$ -25.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 70.89M$ 67.35M$ 71.52M$ 80.41M$ 77.41M
Total Assets$ 220.78M$ 218.14M$ 217.89M$ 222.51M$ 229.20M
Total Debt$ 178.25M$ 178.71M$ 179.17M$ 155.37M$ 155.97M
Net Debt$ 107.36M$ 111.36M$ 107.65M$ 74.96M$ 78.56M
Total Liabilities$ 260.78M$ 256.08M$ 251.65M$ 256.48M$ 256.99M
Stockholders Equity$ -40.01M$ -37.94M$ -33.77M$ -33.97M$ -27.79M
Cash Flow-
Free Cash Flow$ 2.94M$ -5.24M$ -9.52M$ 2.21M$ -9.97M
Operating Cash Flow$ 3.37M$ -4.60M$ -9.52M$ 2.46M$ -9.18M
Investing Cash Flow$ 3.97M$ 2.05M$ 1.28M$ -8.84M$ -23.22M
Financing Cash Flow$ 14.00K$ 492.00K$ 11.00K$ 199.00K$ 53.80M
Currency in USD

Heron Therapeutics Earnings and Revenue History

Heron Therapeutics Debt to Assets

Heron Therapeutics Cash Flow

Heron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis